The National Institutes of Health will terminate all funding for grants involving risky gain-of-function research and give researchers until the end of June to say whether their grants comply with ...

The man Donald Trump hand-picked to run America’s medical research empire has defended axing billions of dollars in grants, ...

Sen. Rand Paul (R-KY) is calling on Dr. Anthony Fauci to appear again before the Senate after exposing emails from Fauci that conflict with statements he made before Congress. Documents obtained by ...

After quitting most methods of birth control, you’ll return to normal fertility within a few menstrual cycles or sooner. The ...

The results show that using a single 2-in-1 anti-inflammatory reliever inhaler – which combines the inhaled corticosteroid (ICS) budesonide and the fast-acting bronchodilator formoterol – reduced ...

Recent scientific work led by Dr. Peter Daszak and researchers at Nature.Health.Global (NHG) has drawn urgent attention to the coronavirus threat in Asia, especially a virus known as swine acute ...

(TNND) — Health Secretary Robert F. Kennedy Jr. defended his "Make America Healthy Again" agenda during a heated congressional hearing on Thursday against members of both parties. Kennedy testified ...

Despite notoriously denying antidepressant harms—including devastating Post-SSRI Sexual Dysfunction (PSSD)—Anita Clayton is now leading the society that shapes the psychiatric industry’s drug policies ...

Biosafety hawks were initially optimistic that the incoming second Trump administration would at last place binding constraints on so-called ...

Journal Editorial Report: The Fed Chief signals rate cuts are coming. As we saw during the Covid pandemic, lab-created experiments can wreak havoc when they escape their confines. Once released, they ...

Scientific evidence for a possible chemical residue of past life on Mars has withstood a year of analysis and independent peer review, adding credibility to what can now only be confirmed if the ...

Extension of the Phase 1b study will allow participants to continue dosing with GT-02287 for an additional nine months after completing the first ...